Market Research Insights

  San Francisco, 12 Novembers 2025:  The Report  Oligonucleotide Synthesis Market  (2025 - 2030) Size, Share & Trends Analysis Report By Product (Oligonucleotides, Reagents, Services, Equipment/Synthesizer), By Application (PCR Primers, Sequencing, DNA Microarrays), By End-use, By Region, And Segment Forecasts The global oligonucleotide synthesis market size is expected to reach USD 8.83 billion by 2030, registering a CAGR of 13.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. The strong pipeline of oligonucleotide therapeutics in clinical trials, advancements in gene editing technologies, and increasing R&D spending by biotechnology companies are some of the major factors driving the market growth. Oligonucleotide therapeutics participants are present in the late stages of clinical trials and are expected to be approved & commercialized over the forecast period. Companies have increased investments to develop ol...

San Francisco, 27 May 2019:  The Report  Oligonucleotide Synthesis Market  Size, Share & Trends Analysis Report By End Use, By Product (Column-based, Array-based, Services), By Application (PCR Primer, FISH), And Segment Forecasts, 2018 – 2025 The global Oligonucleotide Synthesis Market size is expected to reach USD 3.9 billion by 2025 at a 12.4% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Continuous rise in usage of oligonucleotide synthesis across various aspects of human health management, from molecular diagnostics to therapeutics, is spurring revenue growth. The recent success of oligonucleotide-based drugs in medicine due to increase in number of FDA-approved products is anticipated to boost revenue generation in this market. As of September 2017, there are six approved oligonucleotide therapeutic products. A substantial number of oligos are being investigated for their usage in targeting various infectious...